Search Results 1501-1510 of 16823 for monoclonal antibody

1. Clinical trials - Oncology (Medical)

   The purpose of this study is to assess the feasibility and develop procedures for detecting monoclonal proteins via finger pick blood spots and saliva. Data ...

2. Clinical trials - Oncology (Medical)

   The purpose of this study is to assess the feasibility and develop procedures for detecting monoclonal proteins via finger pick blood spots and saliva. Data ...

3. Scleroderma Registry - Mayo Clinic

   very early diagnosis of systemic sclerosis (VEDOSS) defined as Raynaud's, puffy digits, and abnormal nailfold capillaries or positive autoantibody. Patients ...

4. Phase III Study to Evaluate the Efficacy and Safety of the INTERCEPT Blood System for Red Blood Cells in Patients Undergoing Complex Cardiac Surgery Procedures - Mayo Clinic

   Confirmed positive baseline serum/plasma antibody specific to INTERCEPT RBCs (S-303 specific antibody) screening panel prior to randomization. 2. Pregnant ...

5. A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1) - Mayo Clinic

   ... antibody or with anti-CTLA4 antibody in adult participants with advanced (unresectable or metastatic) cutaneous melanoma. Participation eligibility.

6. Study the Variations in the Humoral and Cellular Immune System in Healthy Volunteers - Mayo Clinic

   Subjects that have an antibody incompatibility at the time of their baseline testing or develop an antibody incompatibility. Participating Mayo Clinic ...

7. Inflammatory Bowel Disease Clinical Trials - Mayo Clinic Research

   ... antibodies-to-infliximab, and evaluate how soon after initiation of ... This observational study will collect blood samples to measure sustained antibody ...

8. Mayo Clinic Minute: Advances in multiple myeloma treatment

   We call it an immunoglobulin, or in our world, we call it a monoclonal protein. And so that can cause damage over time," says Dr. Cook. The damage caused by ...

9. Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) - Mayo Clinic

   ... antibody (including ipilimumab, tremelimumab or any other antibody, or drug specifically targeting T cell co stimulatory or immune checkpoint pathways).

10. A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL) - Mayo Clinic

    Prior treatment with an anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CD137, or anti-CTLA-4 antibody, or any other antibody or drug specifically targeting T-cell co- ...